0001811468-20-000001.txt : 20200508 0001811468-20-000001.hdr.sgml : 20200508 20200508150717 ACCESSION NUMBER: 0001811468-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 EFFECTIVENESS DATE: 20200508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atsena Therapeutics, Inc. CENTRAL INDEX KEY: 0001811468 IRS NUMBER: 845181493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366568 FILM NUMBER: 20860145 BUSINESS ADDRESS: STREET 1: 280 S. MAGNUM STREET, SUITE 350 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 352-273-9342 MAIL ADDRESS: STREET 1: 280 S. MAGNUM STREET, SUITE 350 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001811468 Atsena Therapeutics, Inc. 280 S. MAGNUM STREET, SUITE 350 DURHAM NC NORTH CAROLINA 27701 352-273-9342 DELAWARE VectorEyes, Inc. None Corporation true 2019 Patrick Ritschel c/o Atsena Therapeutics, Inc. 280 S. Magnum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Executive Officer Director Benjamin Yerxa c/o Atsena Therapeutics, Inc. 280 S. Magnum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Director Michael Dial c/o Atsena Therapeutics, Inc. 280 S. Magnum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Director Shannon Boye c/o Atsena Therapeutics, Inc. 280 S. Magnum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Executive Officer Director Sanford Boye c/o Atsena Therapeutics, Inc. 280 S. Magnum Street, Suite 350 Durham NC NORTH CAROLINA 27701 Executive Officer Biotechnology Decline to Disclose 06b false 2020-04-24 false true true Preferred Stock can convert to underlying shares of Common Stock. false 0 8149978 4074989 4074989 Total Remaining to be Sold has been accounted for, and will be issued and sold upon meeting certain milestones. false 7 0 0 0 false Atsena Therapeutics, Inc. /s/ Patrick Ritschel Patrick Ritschel Chief Executive Officer 2020-05-06